J&J Expands R&D in India

Johnson & Johnson Pharmaceutical Research & Development (J&JPRD; Raritan, NJ) and Janssen-Cilag, the pharmaceutical business of J&J, have expanded their jointly operated analytical and pharmaceutical development center (APDC) at Mumbai and are building a pharma research facility at the same site. The APDC, due to open at the end of 2008, will be a hub for analytical and pharmaceutical formulation development processes, and for increasing overall capacity to discover and develop new pharmaceuticals, the company...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers